...
首页> 外文期刊>Oncology letters >Giant and high-risk gastrointestinal stromal tumor in the abdomino-pelvic cavity: A case report
【24h】

Giant and high-risk gastrointestinal stromal tumor in the abdomino-pelvic cavity: A case report

机译:腹盆腔巨大而高危胃肠道间质瘤1例

获取原文
获取原文并翻译 | 示例

摘要

Gastrointestinal stromal tumors (GISTs) are benign mesenchymal tumors of the gastrointestinal tract. The clinical presentations of patients with GIST are variable and may be non-specific. The current study reports the case of a 66-year-old man that presented with a gradual enlargement of the abdomen, emaciation, hyperhidrosis and frequent and urgent micturition. A computed tomography (CT) scan of the abdomen revealed a large, heterogeneous, low density mass that occupied the entire abdomino-pelvic cavity. Magnetic resonance imaging (MRI) identified a high signal intensity on the T2 weighted image and an intermediate signal intensity on the T1 weighted image. A contrast enhanced CT scan and MRI demonstrated the uptake of contrast material. A biopsy revealed that the tumor was composed of spindle cells, and immunohistochemical analysis identified the presence of mast/stem cell growth factor receptors. Together, these results lead to a diagnosis of GIST. The clinical findings, imaging modalities and pathological studies suggested that the GIST was a large and high-risk tumor located in the abdomino-pelvic cavity. The final surgical results confirmed these findings. Following conservative treatment with imatnib (400 mg, daily) for 6 months, the tumor became smaller and was suitable for surgery, which the patient received in December 2014. The final surgery confirmed the high-risk GIST. Subsequent to the surgery, the patient was recommended to continue the use of imatnib with regular CT or MRI reexaminations every 3 months, which are planned to continue for 3 years.
机译:胃肠道间质瘤(GIST)是胃肠道的良性间质肿瘤。 GIST患者的临床表现是可变的,可能是非特异性的。当前的研究报道了一例66岁的男性,腹部逐渐增大,消瘦,多汗症和频繁而紧急的排尿。腹部的计算机断层扫描(CT)扫描显示,大的,异质的,低密度的肿块占据了整个腹盆腔。磁共振成像(MRI)在T2加权图像上识别出高信号强度,在T1加权图像上识别出中等信号强度。对比增强的CT扫描和MRI证实了对比材料的摄取。活检显示肿瘤由梭形细胞组成,免疫组织化学分析确定了肥大/干细胞生长因子受体的存在。这些结果共同导致对GIST的诊断。临床发现,影像学方法和病理研究表明,GIST是位于腹盆腔的大型高危肿瘤。最终的手术结果证实了这些发现。在接受伊马替尼(400 mg,每天)的保守治疗6个月后,肿瘤变小并且适合手术,患者于2014年12月接受了手术。最终手术证实了高危GIST。手术后,建议患者每3个月继续使用伊马替尼,并定期进行CT或MRI复查,并计划连续3年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号